UPM progresses transformation toward 'new innovation-driven businesses,' forms new unit--inheriting UPM Biorefining name--that combines biofuels, biochemicals, biomedicals, biocomposites; UPM Pulp and Timber to be reported as new business area, UPM Fibres

Sample article from our Bioeconomy

LOS ANGELES , March 10, 2022 () –

UPM Kymmene Oyj is forming a new business unit that combines biofuels, biochemicals, biomedicals and biocomposites under one division as part of the company’s transformation to “new innovation-driven businesses,” UPM president and CEO Jussi Pesonen told investors during the company's Q4 2021 earnings call.

“The aim is to speed up the business growth and to leverage the capabilities and competencies across the project efficiently,” he said.

The new unit will inherit the name of UPM Biorefining and will be reported as part of UPM’s other operations, at least for the time being, Pesonen said. Because the name UPM Biorefining is now taken, UPM Pulp and Timber will be reported as a new business area, called UPM Fibres. These changes were slated to take place in early 2022.

Meanwhile, work on UPM’s €550 million biochemicals plant in Leuna, Germany, is “moving at a good pace,” Pesonen said. He added there’s “keen interest” on various products of the new, 100% wood-based biochemicals refinery, which “really confirms the business opportunity and long-term growth strategy in biochemicals.”

The total annual capacity of the biorefinery will be 220,000 tonnes of bio-monoethylene glycol (BioMEG) and lignin-based renewable functional fillers. In addition, the biorefinery will produce bio-monopropylene glycol (BioMPG) and industrial sugars made from sustainably harvested beechwood sourced regionally in Germany.

The decision to build Leuna was made in late January 2020, just before COVID-19 lockdowns, which was “a bit unfortunate,” he said. The pandemic slowed down completion of detailed engineering in the early part of the project, which normally would have been recoverable through mitigation actions, but successive waves of the pandemic and disruption of the global supply chain made that unfeasible.

As a result, UPM updated its schedule and now expects to start up Leuna at the end of 2023. However, R&D facilities on site are being extended, and the application development center for rubber and glycols is now operational.

“This enables us to continue the commercial activities and testing at the full speed with our future customers in various end uses,” Pesonen said.

He also updated investors on UPM’s biofuels growth plan. Basic engineering of UPM’s next-generation biofuels refinery has now reached the point where the company has completed site assessments in Kotka, Finland, and Rotterdam, Netherlands. UPM has decided work will continue in Rotterdam, “where the operating environment is more favorable for the biofuels business."

However, the current investment environment – in terms of costs, resources and logistics – “is very challenging for major projects like this,” he said. “Therefore, we are not planning to make further decisions until the end of 2022.”

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order bioeconomy coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.